The burden of cervical cancer varies considerably in the European Union. In this paper, we describe trends in incidence of and mortality from this cancer in the five most affected member states.
Methods
Data on number of deaths from uterine cancers and the size of the female population of Estonia, Latvia, Lithuania, Bulgaria and Romania were extracted from the WHO mortality database. Mortality rates were corrected for inaccuracies in the death certification of not otherwise specified uterine cancer. Incidence data were obtained from the national cancer registries. Joinpoint regression was used to study the annual variation of corrected and standardized incidence and mortality rates. Changes by birth cohort were assessed for specific age groups and subsequently synthesized by computing standardized cohort incidence/mortality ratios.
Results
Joinpoint regression revealed rising trends of incidence (in Lithuania, Bulgaria and Romania) and of mortality (in Latvia, Lithuania, Bulgaria and Romania). In Estonia, rates were rather stable. Women born between 1940 and 1960 were at continuously increasing risk of both incidence of and mortality from cervical cancer.
Conclusions
Rising trends of cervical cancer in the most affected EU member states reveal a worrying pattern that warrants urgent introduction of effective preventive actions as described in the European guidelines.
ArbynM., RaifuA.O., AutierP., FerlayJ.: Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol, 18: 1708–1715, 2007.
2.
ArbynM., AutierP., FerlayJ.: Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol, 18: 1425–1427, 2007.
3.
FerlayJ., BrayF., PisaniP., ParkinD.M.: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. IARCPress, Lyon, 2004.
European Commission: European Guidelines for Quality Assurance in Cervical Cancer Screening.2nd ed.Office for Official Publications of the European Communities, Luxembourg, 2008.
6.
ArbynM., AnttilaA., JordanJ., RoncoG., SchenckU., SegnanN., WienerH., HerbertA., von KarsaL.: European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition - Summary Document. Ann Oncol, 21: 448–458, 2010.
7.
ArbynM., RaifuA.O., AntoineJ.: Trends of cervical cancer mortality in Europe. IPH/EPI-REPORTS 2009–07: 1–54, 2009.
8.
ArbynM., AntoineJ., MägiM., SmailyteG., StengrevicsA., SuteuO., ValerianovaZ., BrayF., WeiderpassE.: Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania. Int J Cancer2010 (epub ahead of print).
9.
ArbynM., RaifuA.O., BrayF., WeiderpassE., AnttilaA.: Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer, 45: 2640–2648, 2009.
10.
WaterhouseJ.A.H., MuirC.S., ShanmugaratnamK.: Cancer Incidence in Five Continents.4 ed.International Agency for Research on Cancer, Lyon, 1976.
11.
National Cancer Institute: Join Point Regression Programme. Version 3.2. (Software produced by the Statistical Research and Application Branch), 2008.
KimH-J, FayM.P., FeuerE.J., MidthuneD.N.: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19: 335–351, 2000.
14.
DevesaS.S., DonaldsonJ., FearsT.: Graphical presentation of trends in rates. Am J Epidemiol, 141: 300–304, 1995.
15.
ArbynM., Van OyenH., SartorF., TibaldiF., MolenberghsG.: Description of the influence of age, period and cohort effects on cervical cancer mortality by loglinear Poisson models (Belgium, 1955–94). Arch Public Health, 60: 73–100, 2002.
16.
BeralV.: Cancer of the cervix: a sexually transmitted infection?Lancet, 25: 1037–1040, 1974.
17.
OsmondC., GardnerM.J.: Age, Period and Cohort Models Applied to Cancer Mortality Rates. Stat Med, 1: 245–259, 1982.
18.
IARC Monograph Working Group: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 90: Human Papillomaviruses. IARCPress, Lyon, 2007.
19.
IARC: Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. IARCPress, Lyon, 2005.
20.
LaaraE., DayN.E., HakamaM.: Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet, 1: 1247–1249, 1987.
21.
BrayF., LoosA.H., McCarronP., WeiderpassE., ArbynM., MollerH., HakamaM., ParkinD.M.: Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev, 14: 677–686, 2005.
22.
ZakeljM.P., KirnV.P., SkrlecF., SelbJ.: Can we rely on cancer mortality data? Checking the validity of cervical cancer mortality data for Slovenia. Radiol Oncol, 35: 243–247, 2002.
23.
SuzanF., SéblainC., Boussac-RarebskaM., PoillotM.L., ArveuxP., LaurentF., CarréN.: Survey on the distribution of “uterus cancer, cervix corpus cancer and not otherwise specified cancer” among death certificates for cervix cancer and corpus uteri cancer, France. Bull Epidemiol Hebdom, 9: 79–81, 2007.
24.
CapocacciaR., MartinaL., InghelmannR., CrocettiE., DeL.V., FalciniF., GuzzinatiS., RossoS., TagliabueG., TuminoR., VercelliM., ZanettiR., De AngelisR.: A method to estimate mortality trends when death certificates are imprecisely coded: an application to cervical cancer in Italy. Int J Cancer, 124: 1200–1205, 2009.
25.
ParkinD.M., BrayF.I., DevesaS.S.: Cancer burden in the year 2000. The global picture. Eur J Cancer, 37: 4–66, 2001.
26.
LaukkanenP., KoskelaP., PukkalaE., DillnerJ., LaaraE., KnektP., LehtinenM.: Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol, 84: 2105–2109, 2003.
27.
LehtinenM., KaasilaM., PasanenK., PatamaT., PalmrothJ., LaukkanenP., PukkalaE., KoskelaP.: Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomavirusesin Finland in the 1980s and 1990s. Int J Cancer, 119: 2612–2619, 2006.
28.
International Collaboration of Epidemiological studies of cervical cancer: Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer, 118: 1481–1495, 2006.
29.
SmithJ.S., GreenJ., Berrington de GonzalezA., ApplebyP., PetoJ., PlummerM., FranceschiS., BeralV.: Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet, 361: 1159–1167, 2003.
30.
QuinnM., BabbP., JonesJ.: Effect of Screening on Incidence an Mortality from Cancer of the Cervix in England: Evaluation Based on Routinely Collected Statistics. BMJ, 318: 904–908, 1999.
31.
NygardJ.F., SkareG.B., ThoresenS.O.: The cervical cancer screening programme in Norway, 1992–2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen, 9: 86–91, 2002.
32.
ReboljM., van BallegooijenM., BerkersL.M., HabbemaJ.D.F.: Monitoring a national cancer prevention programme: Successful changes in cervical cancer screening in the Netherlands. Int J Cancer, 120: 806–812, 2007.
33.
AnttilaA., NieminenP.: Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol, 31(Suppl 2): 17–22, 2007.
34.
ArbynM., GeysH.: Trend of cervical cancer mortality in Belgium (1954–94): tentative solution for the certification problem of not specified uterine cancer. Int J Cancer, 102: 649–654, 2002.
35.
NiculaF., AnttilaA., NeamtiuL., Zakelj-PrimicM., TachezyR., ChilA., GrceM., KesicV.: Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. Eur J Cancer, 45: 2679–2684, 2009.
36.
SuteuO., LazarL., IrimieA., NiculaF., CozaD., DumaM., PaisR., NeamtiuL.: Organization and implementation of cervical screening pilot program in County of Cluj, Transilvania. In: Fifth Proceedings of the International Multidisciplinary Congress EUROGIN 2003, Paris, 2003.
37.
SantM., AareleidT., BerrinoF., BielskaL.M., CarliP.M., FaivreJ., GrosclaudeP., HedelinG., MatsudaT., MollerH., MollerT., VerdecchiaA., CapocacciaR., GattaG., MicheliA., SantaquilaniM., RoazziP., LisiD.: EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol, 14: 61–118, 2003.
38.
GondosA., BrayF., BrewsterD.H., CoeberghJ.W., HakulinenT., Janssen-HeijnenM.L., KurtinaitisJ., BrennerH.: Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer, 44(10): 1463–1475, 2008.
39.
Bielska-LasotaM., InghelmannR., Poll-FranseL., CapocacciaR.: Trends in cervical cancer survival in Europe, 1983–1994: a population-based study. Gynecol Oncol, 105: 609–619, 2007.
40.
KostovaP., ZlatkovV., DanonS.: Five-year overall survival and prognostic factors in patients with cervical cancer in Bulgaria. J BUON, 13: 363–368, 2008.
41.
Council of the European Union: Council Recommendation of 2 December 2003 on Cancer Screening. Off J Eur Union, 878: 34–38, 2003.
42.
ArbynM., Primic ZakeljM., RaifuA.O., GrceM., ParaskevaidisE., DiakomanolisE., KesicV., NiculaF., SuteuO., von KarsaL.: The burden of cervical cancer in South-East Europe at the beginning of the 21st century. Coll Antropol, 31: 7–10, 2007.
